Line up of positive news flow going forward might include. a) New CEO pharma industry vet b) awesome 700mg Nash data c) BLA for HIV d) partnership with cash infusion e) well subscribed secondary offering f) enrollments in trials g) end of SEC investigation where focus squarely on Nader and not company.